Incyte Corp. Stock
Price
Target price
€52.44
€52.44
-0.760%
-0.4
-0.760%
€78.42
13:13 / Tradegate
WKN: 896133 / Symbol: INCY / Name: Incyte / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Incyte Corp. Stock
Incyte Corp. shows a slight decrease today, losing -€0.400 (-0.760%) compared to yesterday.
We see a rather positive sentiment for Incyte Corp. with 12 Buy predictions and 2 Sell predictions.
With a target price of 78 € there is a positive potential of 48.74% for Incyte Corp. compared to the current price of 52.44 €.
Our community identified positive and negative aspects for Incyte Corp. stock for the coming years. 1 users see the criterium "EBIT growth" as a plus for the Incyte Corp. stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.
Pros and Cons of Incyte Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Incyte Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Incyte Corp. | -0.760% | 0.648% | 9.422% | -9.396% | -6.873% | -22.567% | -26.355% |
| Exact Sciences | -1.010% | -0.831% | -16.391% | -39.859% | -32.934% | -48.591% | -46.602% |
| Regeneron Pharmaceuticals Inc. | 0.510% | 0.465% | 10.010% | 34.389% | 13.831% | 122.773% | 227.312% |
| Amgen Inc. | 1.150% | -1.948% | 11.710% | 39.279% | 8.173% | 44.106% | 83.960% |
Comments
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at TD Cowen from $88.00 to $80.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $83.00 price target on the stock, down previously from $84.00.
Show more
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $92.00 to $84.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for INCY provided by MarketBeat
